Skip to main content
. 2019 Jul 9;9:553. doi: 10.3389/fonc.2019.00553

Figure 2.

Figure 2

Lung metastases from uterine leiomyosarcoma right before starting Trabectedin in November 2015 (A) showing an almost complete response after treatment in February 2016 (B). Systemic therapy was then suspended for a drug holiday. During this period the lesion began to grow again in December 2017 (C). However, in March 2018 after Trabectedin re-challenge a new partial response was observed (D).